Literature DB >> 2415598

Sequence similarities and cross-idiotypic specificity of L chains among human monoclonal IgM kappa with anti-gamma-globulin activity.

F Goñi, P P Chen, B Pons-Estel, D A Carson, B Frangione.   

Abstract

The complete amino acid sequence of five light chain variable (V) regions of human monoclonal IgM kappa rheumatoid factors (RF) was determined, and their cross-reactive idiotypes (CRI) were characterized with antibodies induced by immunization with synthetic peptides PSL2 and PSL3, corresponding to the second and third complementarity-determining regions (CDR) of the SIE light chain. Together with two additional RF studied previously, all seven RF belong to the V kappa IIIb sub-subgroup. The region encoded by the V kappa gene segment (positions 1 to 95) in all seven proteins was virtually identical in primary structure, whereas the sequence from positions 96 to 108 defined the usage of the J kappa 1 gene in three proteins and the J kappa 2 gene in four of them. Position 96 contributed by the recombination of the V kappa and J kappa gene segments showed the presence of four different amino acid residues. Both anti-PSL2 and anti-PSL3 bind efficiently to all separated L chains when analyzed by the Western blot technique, and the binding was inhibited specifically by the corresponding peptides. The results reveal that the majority of human IgM-RF light chains are derived from a single germ line V kappa gene or a family of closely related V kappa III germ line genes, and express two "primary structure-dependent" CRI, which are largely dependent on the amino acid sequence of the second and third light chain CDR.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415598

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors:  W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 2.  Generation of stable human autoantibody-secreting B cell hybridomas.

Authors:  N Chiorazzi
Journal:  Mol Biol Rep       Date:  1992-05       Impact factor: 2.316

3.  Genetic basis for the cross-reactive idiotypes on the light chains of human IgM anti-IgG autoantibodies.

Authors:  P P Chen; K Albrandt; N K Orida; V Radoux; E Y Chen; R Schrantz; F T Liu; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  A human monoclonal IgA rheumatoid factor using the VkIV light chain gene.

Authors:  R Mierau; A Gause; R Küppers; M Michels; R A Mageed; R Jefferis; E Genth
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 5.  Genes regulating rheumatoid factors.

Authors:  C A Bona
Journal:  Springer Semin Immunopathol       Date:  1988

Review 6.  Molecular basis for cryoprecipitation.

Authors:  A C Wang
Journal:  Springer Semin Immunopathol       Date:  1988

Review 7.  Cross-reacting idiotypes on cryoprecipitating rheumatoid factor.

Authors:  P P Chen; S Fong; F Goni; G J Silverman; R I Fox; M F Liu; B Frangione; D A Carson
Journal:  Springer Semin Immunopathol       Date:  1988

Review 8.  Idiotypes and the structural diversity of human rheumatoid factors.

Authors:  S Fong; P P Chen; J J Crowley; G J Silverman; D A Carson
Journal:  Springer Semin Immunopathol       Date:  1988

9.  Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms.

Authors:  R C Williams; N J Marshall; K Kilpatrick; J Montano; P M Brickell; M Goodall; P A Ealey; B Shine; A P Weetman; R K Craig
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans.

Authors:  G J Silverman; R D Goldfien; P Chen; R A Mageed; R Jefferis; F Goñi; B Frangione; S Fong; D A Carson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.